market access
Digital/ Market Access/ News/ News/ News
AmerisourceBergen aims to make digital therapeutics access easier
Phil Taylor
AmerisourceBergen, digital, digital health, digital therapeutics, market access
0 Comment
Digital/ Partner content/ Press releases
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Marketing
#medcomms, market access, MSL, omnichannel, sales rep
0 Comment
Deep Dive/ Market Access/ Views & Analysis
ICSs: improving patient and market access at a local level
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Market Access, Dr Paul Tunnah, IQVIA, Jim McArdle, market access, Matthias Winker, Steven Ferguson, Uday Bose
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Time is motor neurons – the importance of newborn screening in SMA
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Market Access, market access, Mike Fraser, Novartis Gene Therapies, spinal muscular atrophy
0 Comment
Market Access/ Patients/ Views & Analysis/ Views & Analysis/ Views and analysis
Questions linger as England’s Innovative Medicines Fund kicks off
Leela Barham
Innovative Medicines Fund, market access, NHS, NICE
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Is it time to rethink electronic prescribing in the US?
mike.hammerton@pharmaphorum.com
Bob Katter, Deep Dive, Deep Dive: Market Access, market access
0 Comment
Market Access/ Partner content/ Press releases
Data-driven policy and market access firm Avalere joins Fishawack Health
Fishawack Marketing
health economics outcomes research, market access, policy, pricing, regulation
0 Comment
Deep Dive/ Market Access/ Views & Analysis/ Views and analysis
Combination pricing: access to the future of oncology treatment relies on collaboration
mike.hammerton@pharmaphorum.com
Deep Dive, Deep Dive: Market Access, market access, Oncology, Sanofi
0 Comment